HK Stock MarketDetailed Quotes

01513 LIVZON PHARMA

Watchlist
  • 26.650
  • -0.200-0.74%
Market Closed Mar 28 16:08 CST
24.69BMarket Cap11.31P/E (TTM)

About LIVZON PHARMA Company

The company was founded in January 1985, with a registered capital of 719 million yuan. As of 2017, the company had total assets of 16 billion yuan, annual operating income of 8.53 billion yuan, deducting non-net profit of 820 million yuan, and R&D investment of 575 million yuan. In 1993, Lizhu's A and B shares were listed one after another; at the beginning of the 2014 new year, the company completed the conversion of B shares to H shares, making it one of the few A+H share pharmaceutical listed companies in the capital market. The company's main business is R&D, production and sales of pharmaceutical products. The main products include iLiriam (eprazole enteric tablets and eprazole sodium for injection), Ributerol (potassium bismuth citrate) series products, liberol (labeprazole sodium enteric capsules), vitamin triplets (potassium bismuth citrate tablets/tinidazole tablets/clarithromycin tablets), Bei (injectable leuprorelin acetate microspheres), lisenbao (urethromycin for injection), levodexin (ureconazole for injection), rifocon (progesterone for injection), rifocon (voriconazole for injection), rifolacin (progesterone for injection), rifocon (voriconazole for injection), rifolacin (progesterone for injection), rifocon (voriconazole for injection), rifukon (voriconazole for injection), rifolacin (progesterone for injection), rifolacin (voriconazole for injection), rifukon (voriconazole for injection), rifukon (voriconazole for injection), rifukon (voriconazole for injection) Pharmaceutical products such as loxamine maleate (fluvoxamine maleate tablets), clentin (piropyrone hydrochloride tablets), ginseng fuzheng injections, antiviral granules, etc.; mevastatin, A APIs and intermediates such as carbose, colistin sulfate, phenylalanine, vancomycin hydrochloride, daptomycin, milbehime, and ceftriaxone; novel coronavirus (2019-nCoV) IgM/IgG antibody test kit (colloidal gold method enterprise honor: Lizhu Delle won the first Grand Prize for Outstanding Contribution to Scientific and Technological Advancement in Zhuhai; Lizhu Giang Le won the Grand Prize for Outstanding Contribution to the Advancement of Science and Technology in Zhuhai; Lizhu Xile won the Grand Prize for Outstanding Contribution to Advancing Scientific and Technological Progress by Zhuhai; Lizhu Ziluo Injection won the Grand Prize for Outstanding Contribution to Advancing Science and Technology; Participating in Fuzheng Fuqifu Injection It won the first prize of the 2006 Science and Technology Award of the Chinese Society of Integrated Traditional Chinese and Western Medicine, etc.

Company Profile

Symbol01513
Company NameLIVZON PHARMA
ISINCNE100001QV5
Listing Date01/16/2014
Founded01/26/1985
RegistrationChina
ChairmanBaoguo Zhu
SecretaryLiang Yang
Audit InstitutionGrant Tung Certified Public Accountants (Special General Partnership)
Company CategoryMainland registration of Mainland Individuals control
Registered OfficeHeadquarters Building, No. 38 Chuangye North Road, Jinwan District, Zhuhai, Guangdong
Head Office and Principal Place of BusinessRoom 1301, 13th floor, Wantong Insurance Centre, 38 Gloucester Road, Wanchai, Hong Kong
Fiscal Year Ends12-31
Employees9005
MarketHong Kong motherboard
Phone86-0756-8135990
Fax86-0756-8891070
EmailLIVZON_GROUP@livzon.com.cn
Business Production and sale of self-produced Chinese and Western APIs, pharmaceutical intermediates, Chinese herbal medicines, Chinese medicine tablets, medical devices, health materials, health products, medicinal cosmetics, Chinese and Western pharmaceuticals, biochemical reagents, and also engages in chemical, food and information business, pharmaceutical raw materials, medical diagnostic equipment and reagents; research and development of new pharmaceutical products, transfer of technological achievements; management services; leasing of medical diagnostic equipment; business of the company's own products and related technology; wholesale of proprietary Chinese medicines, chemical raw materials and their preparations, antibiotic raw materials and their preparations, biological products (excluding preventive biological products)), biochemicals. (Commodities involving quota licenses and for which the country has special regulations shall be handled in accordance with relevant regulations; other administrative licensing projects are required and can only be operated after obtaining permission)

Company Executives

  • Name
  • Position
  • Salary
  • Yanggang Tang
  • President,Strategy Committee Member,Executive Director,Authorized Representative
  • 4.34M
  • Guoxiang Xu
  • Executive Director,Vice Chairman of the Board,VP
  • 7.32M
  • Baoguo Zhu
  • Non-Executive Director,Chairman,Strategy Committee Chairman
  • 3.25M
  • Desheng Tao
  • Nomination Committee Member,Vice Chairman,Non-Executive Director,Strategy Committee Member
  • 3.00M
  • Qingfeng Qiu
  • Non-Executive Director
  • 96.00K
  • Xiong Yu
  • Non-Executive Director
  • 96.00K
  • Hua Bai
  • Independent Non-Executive Director,Chairman of the Audit Committee,Remuneration Committee Member
  • 120.00K
  • Huiyuan Luo
  • Nomination Committee Chairman,Audit Committee Members,Independent Non-Executive Director
  • 120.00K
  • Lijie Cui
  • Independent Non-Executive Director,Remuneration Committee Member
  • 120.00K
  • Qiusheng Tian
  • Nomination Committee Member,Independent Non-Executive Director,Remuneration Committee Chairman,Audit Committee Members
  • 120.00K
  • Jinhua Huang
  • Independent Non-Executive Director
  • 120.00K
  • Maolin Wang
  • Supervisory Director,Employee Representative Supervisor
  • 1.38M
  • Huamin Huang
  • Supervisor
  • 48.00K
  • Yin Tang
  • Shareholders' representatives and supervisors
  • 48.00K
  • Daihong Yang
  • VP
  • 3.02M
  • Yanxia Si
  • Head of finance,VP
  • 2.73M
  • Yuxuan Huang
  • VP
  • 3.42M
  • Peng Xu
  • VP
  • 2.34M
  • Liang Yang
  • Authorized Representative,Company Secretary,Company Secretary,VP
  • 2.25M
  • Jun Du
  • VP
  • --
  • Daping Liu
  • VP
  • --
  • Ailing Yuan
  • Alternative Authorized Representative
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg